(Q40403948)

20 September 2017

1 reference

title

A risk-benefit assessment of tacrolimus in transplantation (English)

1 reference

20 September 2017

M Winkler

1

1 reference

PubMed ID

7545405

20 September 2017

U Christians

series ordinal

2

1 reference

20 September 2017

1 May 1995

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

5

1 reference

20 September 2017

348-357

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199512050-00006

20 September 2017

0 references

cites work

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations

1 reference

12 December 2020

Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation

1 reference

12 December 2020

FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects

1 reference

12 December 2020

Conversion from cyclosporin to FK 506 after liver transplantation.

1 reference

12 December 2020

Chronic allograft rejection: an update.

1 reference

12 December 2020

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report

1 reference

12 December 2020

Anaemia associated with FK 506 immunosuppression

1 reference

12 December 2020

Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients

1 reference

12 December 2020

Comparison of Different Assays for the Quantitation of FK 506 Levels in Blood or Plasma

1 reference

12 December 2020

A whole blood FK 506 assay for the IMx analyzer

1 reference

12 December 2020

Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring

1 reference

12 December 2020

Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone

1 reference

12 December 2020

Phase II FK 506 multicenter concentration control study: one-year follow-up.

1 reference

12 December 2020

Renal transplantation in a new immunosuppressive era

1 reference

12 December 2020

Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis

1 reference

12 December 2020

Cyclosporine monitoring in liver allograft recipients: two distinct patterns of blood level derangement associated with nephrotoxicity

1 reference

12 December 2020

Long-term side effects of cyclosporine-based immunosuppression in patients after liver transplantation

1 reference

12 December 2020

Association of elevated FK 506 plasma levels with nephrotoxicity in liver-grafted patients

1 reference

12 December 2020

Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group

1 reference

12 December 2020

Plasma vs whole blood for therapeutic drug monitoring of patients receiving FK 506 for immunosuppression

1 reference

12 December 2020

Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.

1 reference

12 December 2020

Specific and sensitive measurement of FK506 and its metabolites in blood and urine of liver-graft recipients

1 reference

12 December 2020

Long-term consequences of different immunosuppressive regimens for renal allografts

1 reference

12 December 2020

Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation

1 reference

12 December 2020

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients

1 reference

12 December 2020

Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report

1 reference

12 December 2020

Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations

1 reference

12 December 2020

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression

1 reference

12 December 2020

Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).

1 reference

12 December 2020

FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group

1 reference

12 December 2020

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

12 December 2020

FK 506 for liver, kidney, and pancreas transplantation

1 reference

12 December 2020

FK 506 in clinical kidney transplantation

1 reference

12 December 2020

Adverse effects of FK 506 overdosage after liver transplantation

1 reference

12 December 2020

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications

1 reference

12 December 2020

The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation

1 reference

12 December 2020

Preliminary experience with FK506 in thoracic transplantation

1 reference

12 December 2020

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression

1 reference

12 December 2020

Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group

1 reference

12 December 2020

Pharmacokinetics of FK 506 in transplant patients

1 reference

12 December 2020

Liver, kidney, and thoracic organ transplantation under FK 506.

1 reference

12 December 2020

A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation

1 reference

12 December 2020

A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation

1 reference

12 December 2020

OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection

1 reference

12 December 2020

Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group

1 reference

12 December 2020

Neurologic complications of FK 506

1 reference

12 December 2020

10.2165/00002018-199512050-00006

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/txjsascy45cc5kxfwdft4dwzza

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1047674799

0 references

Fatcat ID

release_txjsascy45cc5kxfwdft4dwzza

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/txjsascy45cc5kxfwdft4dwzza

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/txjsascy45cc5kxfwdft4dwzza

30 July 2022